Business Context and Reporting Period
This Form 8-K filing by Pavmed Inc. (PAVM) was submitted on December 30, 2022, reporting an event that occurred on December 29, 2022. The company is incorporated in Delaware and its common stock and Series Z warrants trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory compliance issue regarding the company's stock price.
Material Changes
The material change reported is a notification from Nasdaq regarding the company's failure to meet the minimum bid price requirement for continued listing. Specifically, the closing bid price of the common stock remained below $1.00 per share for 30 consecutive business days through December 28, 2022.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The company has been granted an initial 180-day period (until June 27, 2023) to regain compliance.
- Remediation Requirement: To cure the deficiency, the closing bid price must be at least $1.00 for a minimum of ten consecutive business days.
- Delisting Risk: If compliance is not achieved within the initial 180 days, the company may be eligible for an additional 180-day period. Failure to cure the deficiency after this time, or if Nasdaq determines the company cannot cure it, will result in delisting.
- Current Trading Status: The notification has no immediate effect on trading; the common stock (PAVM) and Series Z warrants (PAVMZ) will continue to trade uninterrupted.
- Management Action: The company intends to consider all available options to regain compliance with Nasdaq listing standards.
Investor Verification Checklist
- Verify the current closing bid price of PAVM to assess progress toward the $1.00 threshold.
- Monitor for any subsequent filings regarding stock splits, reverse splits, or other capital structure changes intended to address the listing deficiency.
- Check for updates on the company's cash position and liquidity, as these factors often influence the ability to execute compliance strategies.
- Review the company's official communications for specific plans to regain compliance before the June 27, 2023 deadline.